Synthetic Biology
Synthetic Biology

Synthetic Biology Comprehensive Study by Type (Core Products {Synthetic DNA, Synthetic Cells, Synthetic Genes, XNA and Chassis Organisms}, Enabling Products {DNA Synthesis and Oligonucleotide Synthesis}), Application (Healthcare, Chemicals, Agriculture, Others), Technology (Genome Engineering, DNA Sequencing, Bioinformatics, Biological Components and Integrated Systems) Players and Region - Global Market Outlook to 2024

Synthetic Biology Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

May 2019 Edition 215 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Synthetic Biology Market Overview:
Synthetic biology is a new interdisciplinary area that involves the application of engineering principle to biology. It is a designing and constructing biological modules, biological systems and biological machines or redesigning of existing biological systems for useful purposes. Synthetic biology researchers and companies around the world are working to solve problems in medicine, manufacturing and agriculture. It is widely used in medical and pharmaceutical fields to produce and manufacture improved biological drugs and systems to solve various challenges in the healthcare sector.

Market Drivers
  • Initiatives by the Government for Research and Development
  • Increased Demand for Better-Quality Drugs and Vaccines

Market Trend
  • Rising Use in Bio-Plastics and Bio-Alcohols

Restraints
  • Issues Related To Environment and Safety

Opportunities
  • Rising Use in Bio-Plastics and Bio-Alcohols
  • Increasing Research and Development Investments

Challenges
  • Ethical Concerns and Stringent Regulations


Competitive Landscape:

Some of the key players profiled in the report are Thermo Fisher Scientific (United States), Novozymes (Denmark), Merck Group (Germany), Intrexon (United States), Agilent Technologies (United States), Amyris (United States), GenScript (United States), Ginkgo Bioworks (United States), Integrated DNA Technologies (United States) and New England Biolabs (United States). Additionally, following companies can also be profiled that are part of our coverage like Synthetic Genomics (United States), Twist Bioscience (United States), Bayer (Germany) and Biosearch Technologies (United Kingdom). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Synthetic Biology market by 2024. Considering Market by Technology, the sub-segment i.e. Genome Engineering will boost the Synthetic Biology market.

Market Highlights:
On 7th March 2018, Agilent Technologies announced that it has signed a definitive agreement to acquire privately-held Advanced Analytical Technologies, Inc. (AATI), a provider of capillary electrophoresis-based (CE) solutions for the fully-automated analysis of a range of molecules.

On 21st September 2018, Thermo Fisher Scientific, released gene synthesis and genome editing products in China. It is helpful to the scientists in China who using synthetic biology for basic research and more targeted translational research and activities initiatives.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Synthetic Biology market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Synthetic Biology market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Synthetic Biology Manufacturers, Research Institutes and Organizations, Government Body & Associations and End-user.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Core Products {Synthetic DNA, Synthetic Cells, Synthetic Genes, XNA and Chassis Organisms}
  • Enabling Products {DNA Synthesis and Oligonucleotide Synthesis}
By Application
  • Healthcare
  • Chemicals
  • Agriculture
  • Others
By Technology
  • Genome Engineering
  • DNA Sequencing
  • Bioinformatics
  • Biological Components and Integrated Systems

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Initiatives by the Government for Research and Development
      • 3.2.2. Increased Demand for Better-Quality Drugs and Vaccines
    • 3.3. Market Challenges
      • 3.3.1. Ethical Concerns and Stringent Regulations
    • 3.4. Market Trends
      • 3.4.1. Rising Use in Bio-Plastics and Bio-Alcohols
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Synthetic Biology, by Type, Application, Technology and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Synthetic Biology (Value)
      • 5.2.1. Global Synthetic Biology by: Type (Value)
        • 5.2.1.1. Core Products {Synthetic DNA, Synthetic Cells, Synthetic Genes, XNA and Chassis Organisms}
        • 5.2.1.2. Enabling Products {DNA Synthesis and Oligonucleotide Synthesis}
      • 5.2.2. Global Synthetic Biology by: Application (Value)
        • 5.2.2.1. Healthcare
        • 5.2.2.2. Chemicals
        • 5.2.2.3. Agriculture
        • 5.2.2.4. Others
      • 5.2.3. Global Synthetic Biology by: Technology (Value)
        • 5.2.3.1. Genome Engineering
        • 5.2.3.2. DNA Sequencing
        • 5.2.3.3. Bioinformatics
        • 5.2.3.4. Biological Components and Integrated Systems
      • 5.2.4. Global Synthetic Biology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Synthetic Biology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novozymes (Denmark)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck Group (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Intrexon (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Agilent Technologies (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Amyris (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GenScript (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Ginkgo Bioworks (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Integrated DNA Technologies (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. New England Biolabs (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Synthetic Biology Sale, by Type, Application, Technology and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Synthetic Biology (Value)
      • 7.2.1. Global Synthetic Biology by: Type (Value)
        • 7.2.1.1. Core Products {Synthetic DNA, Synthetic Cells, Synthetic Genes, XNA and Chassis Organisms}
        • 7.2.1.2. Enabling Products {DNA Synthesis and Oligonucleotide Synthesis}
      • 7.2.2. Global Synthetic Biology by: Application (Value)
        • 7.2.2.1. Healthcare
        • 7.2.2.2. Chemicals
        • 7.2.2.3. Agriculture
        • 7.2.2.4. Others
      • 7.2.3. Global Synthetic Biology by: Technology (Value)
        • 7.2.3.1. Genome Engineering
        • 7.2.3.2. DNA Sequencing
        • 7.2.3.3. Bioinformatics
        • 7.2.3.4. Biological Components and Integrated Systems
      • 7.2.4. Global Synthetic Biology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Synthetic Biology: by Type(USD Million)
  • Table 2. Synthetic Biology Core Products {Synthetic DNA, Synthetic Cells, Synthetic Genes, XNA and Chassis Organisms} , by Region USD Million (2013-2018)
  • Table 3. Synthetic Biology Enabling Products {DNA Synthesis and Oligonucleotide Synthesis} , by Region USD Million (2013-2018)
  • Table 4. Synthetic Biology: by Application(USD Million)
  • Table 5. Synthetic Biology Healthcare , by Region USD Million (2013-2018)
  • Table 6. Synthetic Biology Chemicals , by Region USD Million (2013-2018)
  • Table 7. Synthetic Biology Agriculture , by Region USD Million (2013-2018)
  • Table 8. Synthetic Biology Others , by Region USD Million (2013-2018)
  • Table 9. Synthetic Biology: by Technology(USD Million)
  • Table 10. Synthetic Biology Genome Engineering , by Region USD Million (2013-2018)
  • Table 11. Synthetic Biology DNA Sequencing , by Region USD Million (2013-2018)
  • Table 12. Synthetic Biology Bioinformatics , by Region USD Million (2013-2018)
  • Table 13. Synthetic Biology Biological Components and Integrated Systems , by Region USD Million (2013-2018)
  • Table 14. South America Synthetic Biology, by Country USD Million (2013-2018)
  • Table 15. South America Synthetic Biology, by Type USD Million (2013-2018)
  • Table 16. South America Synthetic Biology, by Application USD Million (2013-2018)
  • Table 17. South America Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 18. Brazil Synthetic Biology, by Type USD Million (2013-2018)
  • Table 19. Brazil Synthetic Biology, by Application USD Million (2013-2018)
  • Table 20. Brazil Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 21. Argentina Synthetic Biology, by Type USD Million (2013-2018)
  • Table 22. Argentina Synthetic Biology, by Application USD Million (2013-2018)
  • Table 23. Argentina Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 24. Rest of South America Synthetic Biology, by Type USD Million (2013-2018)
  • Table 25. Rest of South America Synthetic Biology, by Application USD Million (2013-2018)
  • Table 26. Rest of South America Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 27. Asia Pacific Synthetic Biology, by Country USD Million (2013-2018)
  • Table 28. Asia Pacific Synthetic Biology, by Type USD Million (2013-2018)
  • Table 29. Asia Pacific Synthetic Biology, by Application USD Million (2013-2018)
  • Table 30. Asia Pacific Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 31. China Synthetic Biology, by Type USD Million (2013-2018)
  • Table 32. China Synthetic Biology, by Application USD Million (2013-2018)
  • Table 33. China Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 34. Japan Synthetic Biology, by Type USD Million (2013-2018)
  • Table 35. Japan Synthetic Biology, by Application USD Million (2013-2018)
  • Table 36. Japan Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 37. India Synthetic Biology, by Type USD Million (2013-2018)
  • Table 38. India Synthetic Biology, by Application USD Million (2013-2018)
  • Table 39. India Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 40. South Korea Synthetic Biology, by Type USD Million (2013-2018)
  • Table 41. South Korea Synthetic Biology, by Application USD Million (2013-2018)
  • Table 42. South Korea Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 43. Taiwan Synthetic Biology, by Type USD Million (2013-2018)
  • Table 44. Taiwan Synthetic Biology, by Application USD Million (2013-2018)
  • Table 45. Taiwan Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 46. Australia Synthetic Biology, by Type USD Million (2013-2018)
  • Table 47. Australia Synthetic Biology, by Application USD Million (2013-2018)
  • Table 48. Australia Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 49. Rest of Asia-Pacific Synthetic Biology, by Type USD Million (2013-2018)
  • Table 50. Rest of Asia-Pacific Synthetic Biology, by Application USD Million (2013-2018)
  • Table 51. Rest of Asia-Pacific Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 52. Europe Synthetic Biology, by Country USD Million (2013-2018)
  • Table 53. Europe Synthetic Biology, by Type USD Million (2013-2018)
  • Table 54. Europe Synthetic Biology, by Application USD Million (2013-2018)
  • Table 55. Europe Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 56. Germany Synthetic Biology, by Type USD Million (2013-2018)
  • Table 57. Germany Synthetic Biology, by Application USD Million (2013-2018)
  • Table 58. Germany Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 59. France Synthetic Biology, by Type USD Million (2013-2018)
  • Table 60. France Synthetic Biology, by Application USD Million (2013-2018)
  • Table 61. France Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 62. Italy Synthetic Biology, by Type USD Million (2013-2018)
  • Table 63. Italy Synthetic Biology, by Application USD Million (2013-2018)
  • Table 64. Italy Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 65. United Kingdom Synthetic Biology, by Type USD Million (2013-2018)
  • Table 66. United Kingdom Synthetic Biology, by Application USD Million (2013-2018)
  • Table 67. United Kingdom Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 68. Netherlands Synthetic Biology, by Type USD Million (2013-2018)
  • Table 69. Netherlands Synthetic Biology, by Application USD Million (2013-2018)
  • Table 70. Netherlands Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 71. Rest of Europe Synthetic Biology, by Type USD Million (2013-2018)
  • Table 72. Rest of Europe Synthetic Biology, by Application USD Million (2013-2018)
  • Table 73. Rest of Europe Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 74. MEA Synthetic Biology, by Country USD Million (2013-2018)
  • Table 75. MEA Synthetic Biology, by Type USD Million (2013-2018)
  • Table 76. MEA Synthetic Biology, by Application USD Million (2013-2018)
  • Table 77. MEA Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 78. Middle East Synthetic Biology, by Type USD Million (2013-2018)
  • Table 79. Middle East Synthetic Biology, by Application USD Million (2013-2018)
  • Table 80. Middle East Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 81. Africa Synthetic Biology, by Type USD Million (2013-2018)
  • Table 82. Africa Synthetic Biology, by Application USD Million (2013-2018)
  • Table 83. Africa Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 84. North America Synthetic Biology, by Country USD Million (2013-2018)
  • Table 85. North America Synthetic Biology, by Type USD Million (2013-2018)
  • Table 86. North America Synthetic Biology, by Application USD Million (2013-2018)
  • Table 87. North America Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 88. United States Synthetic Biology, by Type USD Million (2013-2018)
  • Table 89. United States Synthetic Biology, by Application USD Million (2013-2018)
  • Table 90. United States Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 91. Canada Synthetic Biology, by Type USD Million (2013-2018)
  • Table 92. Canada Synthetic Biology, by Application USD Million (2013-2018)
  • Table 93. Canada Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 94. Mexico Synthetic Biology, by Type USD Million (2013-2018)
  • Table 95. Mexico Synthetic Biology, by Application USD Million (2013-2018)
  • Table 96. Mexico Synthetic Biology, by Technology USD Million (2013-2018)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Synthetic Biology: by Type(USD Million)
  • Table 108. Synthetic Biology Core Products {Synthetic DNA, Synthetic Cells, Synthetic Genes, XNA and Chassis Organisms} , by Region USD Million (2019-2024)
  • Table 109. Synthetic Biology Enabling Products {DNA Synthesis and Oligonucleotide Synthesis} , by Region USD Million (2019-2024)
  • Table 110. Synthetic Biology: by Application(USD Million)
  • Table 111. Synthetic Biology Healthcare , by Region USD Million (2019-2024)
  • Table 112. Synthetic Biology Chemicals , by Region USD Million (2019-2024)
  • Table 113. Synthetic Biology Agriculture , by Region USD Million (2019-2024)
  • Table 114. Synthetic Biology Others , by Region USD Million (2019-2024)
  • Table 115. Synthetic Biology: by Technology(USD Million)
  • Table 116. Synthetic Biology Genome Engineering , by Region USD Million (2019-2024)
  • Table 117. Synthetic Biology DNA Sequencing , by Region USD Million (2019-2024)
  • Table 118. Synthetic Biology Bioinformatics , by Region USD Million (2019-2024)
  • Table 119. Synthetic Biology Biological Components and Integrated Systems , by Region USD Million (2019-2024)
  • Table 120. South America Synthetic Biology, by Country USD Million (2019-2024)
  • Table 121. South America Synthetic Biology, by Type USD Million (2019-2024)
  • Table 122. South America Synthetic Biology, by Application USD Million (2019-2024)
  • Table 123. South America Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 124. Brazil Synthetic Biology, by Type USD Million (2019-2024)
  • Table 125. Brazil Synthetic Biology, by Application USD Million (2019-2024)
  • Table 126. Brazil Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 127. Argentina Synthetic Biology, by Type USD Million (2019-2024)
  • Table 128. Argentina Synthetic Biology, by Application USD Million (2019-2024)
  • Table 129. Argentina Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 130. Rest of South America Synthetic Biology, by Type USD Million (2019-2024)
  • Table 131. Rest of South America Synthetic Biology, by Application USD Million (2019-2024)
  • Table 132. Rest of South America Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 133. Asia Pacific Synthetic Biology, by Country USD Million (2019-2024)
  • Table 134. Asia Pacific Synthetic Biology, by Type USD Million (2019-2024)
  • Table 135. Asia Pacific Synthetic Biology, by Application USD Million (2019-2024)
  • Table 136. Asia Pacific Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 137. China Synthetic Biology, by Type USD Million (2019-2024)
  • Table 138. China Synthetic Biology, by Application USD Million (2019-2024)
  • Table 139. China Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 140. Japan Synthetic Biology, by Type USD Million (2019-2024)
  • Table 141. Japan Synthetic Biology, by Application USD Million (2019-2024)
  • Table 142. Japan Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 143. India Synthetic Biology, by Type USD Million (2019-2024)
  • Table 144. India Synthetic Biology, by Application USD Million (2019-2024)
  • Table 145. India Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 146. South Korea Synthetic Biology, by Type USD Million (2019-2024)
  • Table 147. South Korea Synthetic Biology, by Application USD Million (2019-2024)
  • Table 148. South Korea Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 149. Taiwan Synthetic Biology, by Type USD Million (2019-2024)
  • Table 150. Taiwan Synthetic Biology, by Application USD Million (2019-2024)
  • Table 151. Taiwan Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 152. Australia Synthetic Biology, by Type USD Million (2019-2024)
  • Table 153. Australia Synthetic Biology, by Application USD Million (2019-2024)
  • Table 154. Australia Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 155. Rest of Asia-Pacific Synthetic Biology, by Type USD Million (2019-2024)
  • Table 156. Rest of Asia-Pacific Synthetic Biology, by Application USD Million (2019-2024)
  • Table 157. Rest of Asia-Pacific Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 158. Europe Synthetic Biology, by Country USD Million (2019-2024)
  • Table 159. Europe Synthetic Biology, by Type USD Million (2019-2024)
  • Table 160. Europe Synthetic Biology, by Application USD Million (2019-2024)
  • Table 161. Europe Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 162. Germany Synthetic Biology, by Type USD Million (2019-2024)
  • Table 163. Germany Synthetic Biology, by Application USD Million (2019-2024)
  • Table 164. Germany Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 165. France Synthetic Biology, by Type USD Million (2019-2024)
  • Table 166. France Synthetic Biology, by Application USD Million (2019-2024)
  • Table 167. France Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 168. Italy Synthetic Biology, by Type USD Million (2019-2024)
  • Table 169. Italy Synthetic Biology, by Application USD Million (2019-2024)
  • Table 170. Italy Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 171. United Kingdom Synthetic Biology, by Type USD Million (2019-2024)
  • Table 172. United Kingdom Synthetic Biology, by Application USD Million (2019-2024)
  • Table 173. United Kingdom Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 174. Netherlands Synthetic Biology, by Type USD Million (2019-2024)
  • Table 175. Netherlands Synthetic Biology, by Application USD Million (2019-2024)
  • Table 176. Netherlands Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 177. Rest of Europe Synthetic Biology, by Type USD Million (2019-2024)
  • Table 178. Rest of Europe Synthetic Biology, by Application USD Million (2019-2024)
  • Table 179. Rest of Europe Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 180. MEA Synthetic Biology, by Country USD Million (2019-2024)
  • Table 181. MEA Synthetic Biology, by Type USD Million (2019-2024)
  • Table 182. MEA Synthetic Biology, by Application USD Million (2019-2024)
  • Table 183. MEA Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 184. Middle East Synthetic Biology, by Type USD Million (2019-2024)
  • Table 185. Middle East Synthetic Biology, by Application USD Million (2019-2024)
  • Table 186. Middle East Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 187. Africa Synthetic Biology, by Type USD Million (2019-2024)
  • Table 188. Africa Synthetic Biology, by Application USD Million (2019-2024)
  • Table 189. Africa Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 190. North America Synthetic Biology, by Country USD Million (2019-2024)
  • Table 191. North America Synthetic Biology, by Type USD Million (2019-2024)
  • Table 192. North America Synthetic Biology, by Application USD Million (2019-2024)
  • Table 193. North America Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 194. United States Synthetic Biology, by Type USD Million (2019-2024)
  • Table 195. United States Synthetic Biology, by Application USD Million (2019-2024)
  • Table 196. United States Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 197. Canada Synthetic Biology, by Type USD Million (2019-2024)
  • Table 198. Canada Synthetic Biology, by Application USD Million (2019-2024)
  • Table 199. Canada Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 200. Mexico Synthetic Biology, by Type USD Million (2019-2024)
  • Table 201. Mexico Synthetic Biology, by Application USD Million (2019-2024)
  • Table 202. Mexico Synthetic Biology, by Technology USD Million (2019-2024)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Synthetic Biology: by Type USD Million (2013-2018)
  • Figure 5. Global Synthetic Biology: by Application USD Million (2013-2018)
  • Figure 6. Global Synthetic Biology: by Technology USD Million (2013-2018)
  • Figure 7. South America Synthetic Biology Share (%), by Country
  • Figure 8. Asia Pacific Synthetic Biology Share (%), by Country
  • Figure 9. Europe Synthetic Biology Share (%), by Country
  • Figure 10. MEA Synthetic Biology Share (%), by Country
  • Figure 11. North America Synthetic Biology Share (%), by Country
  • Figure 12. Global Synthetic Biology share by Players 2018 (%)
  • Figure 13. Global Synthetic Biology share by Players (Top 3) 2018(%)
  • Figure 14. Global Synthetic Biology share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 17. Thermo Fisher Scientific (United States) Revenue: by Geography 2018
  • Figure 18. Novozymes (Denmark) Revenue, Net Income and Gross profit
  • Figure 19. Novozymes (Denmark) Revenue: by Geography 2018
  • Figure 20. Merck Group (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Merck Group (Germany) Revenue: by Geography 2018
  • Figure 22. Intrexon (United States) Revenue, Net Income and Gross profit
  • Figure 23. Intrexon (United States) Revenue: by Geography 2018
  • Figure 24. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 25. Agilent Technologies (United States) Revenue: by Geography 2018
  • Figure 26. Amyris (United States) Revenue, Net Income and Gross profit
  • Figure 27. Amyris (United States) Revenue: by Geography 2018
  • Figure 28. GenScript (United States) Revenue, Net Income and Gross profit
  • Figure 29. GenScript (United States) Revenue: by Geography 2018
  • Figure 30. Ginkgo Bioworks (United States) Revenue, Net Income and Gross profit
  • Figure 31. Ginkgo Bioworks (United States) Revenue: by Geography 2018
  • Figure 32. Integrated DNA Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 33. Integrated DNA Technologies (United States) Revenue: by Geography 2018
  • Figure 34. New England Biolabs (United States) Revenue, Net Income and Gross profit
  • Figure 35. New England Biolabs (United States) Revenue: by Geography 2018
  • Figure 36. Global Synthetic Biology: by Type USD Million (2019-2024)
  • Figure 37. Global Synthetic Biology: by Application USD Million (2019-2024)
  • Figure 38. Global Synthetic Biology: by Technology USD Million (2019-2024)
  • Figure 39. South America Synthetic Biology Share (%), by Country
  • Figure 40. Asia Pacific Synthetic Biology Share (%), by Country
  • Figure 41. Europe Synthetic Biology Share (%), by Country
  • Figure 42. MEA Synthetic Biology Share (%), by Country
  • Figure 43. North America Synthetic Biology Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Thermo Fisher Scientific (United States)
  • Novozymes (Denmark)
  • Merck Group (Germany)
  • Intrexon (United States)
  • Agilent Technologies (United States)
  • Amyris (United States)
  • GenScript (United States)
  • Ginkgo Bioworks (United States)
  • Integrated DNA Technologies (United States)
  • New England Biolabs (United States)
Additional players considered in the study are as follows:
Synthetic Genomics (United States) , Twist Bioscience (United States) , Bayer (Germany) , Biosearch Technologies (United Kingdom)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation